Mamoru Hyodo Selected Research

Mamoru Hyodo Research Topics

Disease

15	Neoplasms (Cancer) 01/2022 - 04/2005
8	Infections 03/2016 - 03/2005
6	Bites and Stings (Sting) 01/2021 - 02/2011
4	Obesity 03/2014 - 10/2012
4	Body Weight (Weight, Body) 10/2013 - 10/2012
2	Melanoma (Melanoma, Malignant) 01/2021 - 10/2015
2	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2015
2	Reperfusion Injury 12/2015 - 09/2015
2	Renal Cell Carcinoma (Grawitz Tumor) 08/2014 - 01/2012
2	Bacterial Infections (Bacterial Infection) 02/2011 - 08/2008
2	Staphylococcal Infections 07/2009 - 02/2007
2	Persistent Infection 01/2009 - 03/2005
2	Mastitis 08/2005 - 03/2005
1	Dehydration (Water Stress) 09/2021
1	Shock 01/2021
1	Lymphoma (Lymphomas) 03/2016
1	Metabolic Diseases (Metabolic Disease) 03/2014
1	Type 2 Diabetes Mellitus (MODY) 03/2014
1	Disease Progression 03/2014
1	Overweight 03/2014
1	Whooping Cough (Pertussis) 01/2014
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2013
1	Anaplasmosis 02/2009
1	Chronic Disease (Chronic Diseases) 01/2009
1	Pneumococcal Infections 08/2008
1	Communicable Diseases (Infectious Diseases) 08/2008
1	Pneumonia (Pneumonitis) 10/2007
1	Bacterial Pneumonia 10/2007
1	Neuroblastoma 04/2005
1	Colonic Neoplasms (Colon Cancer) 04/2005

Drug/Important Bio-Agent (IBA)

12	bis(3',5')-cyclic diguanylic acidIBA 10/2015 - 03/2005
7	LigandsIBA 01/2021 - 01/2012
7	Small Interfering RNA (siRNA)IBA 03/2016 - 01/2012
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2009
5	InterferonsIBA 01/2021 - 02/2011
4	YSK05IBA 10/2015 - 06/2013
4	Peptides (Polypeptides)IBA 10/2013 - 01/2012
4	Pharmaceutical PreparationsIBA 06/2013 - 04/2005
3	LipidsIBA 10/2015 - 06/2013
3	Liposomes (Liposome)IBA 10/2015 - 06/2014
3	Interferon Type IIBA 10/2015 - 02/2011
3	Nucleotide AptamersIBA 08/2014 - 01/2012
3	Phosphotransferases (Kinase)IBA 06/2014 - 01/2009
3	DNA (Deoxyribonucleic Acid)IBA 05/2013 - 02/2011
3	Vaccine AdjuvantsIBA 07/2009 - 10/2007
2	Lipid NanoparticlesIBA 01/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 08/2014 - 01/2012
2	LeptinIBA 10/2013 - 03/2013
2	NucleotidesIBA 09/2011 - 02/2011
2	Immunologic Factors (Immunomodulators)IBA 08/2008 - 10/2007
2	GpGpIBA 08/2005 - 04/2005
2	Anti-Infective Agents (Microbicides)IBA 04/2005 - 03/2005
1	AcidsIBA 09/2021
1	Silicon Dioxide (Silica)FDA LinkGeneric 09/2021
1	HydrogenIBA 09/2021
1	pristane (pristan)IBA 09/2021
1	allyl alcohol (allylic alcohol)IBA 09/2021
1	SaltsIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	CytokinesIBA 03/2016
1	SphingosineIBA 12/2015
1	Hyaluronic Acid (Hyaluronan)IBA 12/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2015
1	coenzyme Q10 (CoQ10)IBA 09/2015
1	APTIBA 08/2014
1	Troponin T (Troponin T1)IBA 08/2014
1	AntigensIBA 06/2014
1	Adenosine Triphosphate (ATP)IBA 06/2014
1	RNA Helicases (RNA Helicase)IBA 06/2014
1	Blood Glucose (Blood Sugar)IBA 03/2014
1	EnzymesIBA 03/2014
1	AcyltransferasesIBA 03/2014
1	Triglycerides (Triacylglycerol)IBA 03/2014
1	MonoglyceridesIBA 03/2014
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2014
1	ProhibitinsIBA 10/2013
1	CKGGRAKDC-GG-D(KLAKLAK)2IBA 10/2013
1	Messenger RNA (mRNA)IBA 06/2013
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2013
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 05/2013
1	Anti-Obesity Agents (Antiobesity Drugs)IBA 03/2013
1	Cytochromes c (Cytochrome c)IBA 03/2013
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 11/2012
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2012
1	Nucleic AcidsIBA 09/2011
1	RNA (Ribonucleic Acid)IBA 02/2011
1	cyclic diadenosine phosphateIBA 02/2011
1	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 02/2011
1	diguanylate cyclaseIBA 02/2009
1	Histidine KinaseIBA 02/2009
1	N,N'- dipyridoxylethylenediamine- N,N'- diacetic acid (PLED)IBA 02/2009
1	Virulence Factors (Pathogenicity Factors)IBA 01/2009
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2005
1	Epidermal Growth Factor (EGF)IBA 04/2005
1	Acetylcholine (Acetylcholine Chloride)FDA Link 04/2005

Therapy/Procedure

6	Therapeutics 01/2022 - 10/2013
5	Immunotherapy 01/2022 - 06/2014
1	Intravenous Administration 10/2015
1	Injections 01/2014